MARTIN GREEN

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

—

Filings

Unique Clients

Active Period

2009–2010

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2010	—	33	8
2009	—	32	8

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
FABIANI & COMPANY ON BEHALF OF CONCERT PHARMACEUTICALS	—	4	2010
FABIANI & COMPANY ON BEHALF OF CLINICAL DATA, INC.	—	9	2009–2010
FABIANI & COMPANY ON BEHALF OF OCTANE	—	4	2010
FABIANI & COMPANY ON BEHALF OF MEDRAD INC.	—	6	2009–2010
FABIANI & COMPANY ON BEHALF OF TRF COALITION	—	3	2009
FABIANI & COMPANY ON BEHALF OF LUNDBECK RESEARCH USA, INC.	—	7	2009
FABIANI & COMPANY ON BEHALF OF PLANET BIOTECHNOLOGY INC.	—	5	2009
FABIANI & COMPANY ON BEHALF ALNYLAM PHARMACEUTICALS	—	5	2010
FABIANI & COMPANY ON BEHALF OF AUBURN UNIVERSITY	—	8	2009–2010
FABIANI & COMPANY ON BEHALF OF VARIATION BIOTECHNOLOGIES	—	4	2010
FABIANI & COMPANY ON BEHALF OF MEDICAGO INC.	—	7	2009–2010
FABIANI & COMPANY ON BEHALF OF OCERA THERAPEUTICS INC.	—	3	2009

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	50
SENATE	50
Defense, Dept of (DOD)	27
Health & Human Services, Dept of (HHS)	20
Commerce, Dept of (DOC)	10
Agriculture, Dept of (USDA)	7
Natl Institutes of Health (NIH)	5
Natl Science Foundation (NSF)	3
Small Business Administration (SBA)	3
White House Office	2
Employment & Training Administration	1
Labor, Dept of (DOL)	1

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	51
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	18
Defense	Defense	16
Budget/Appropriations	Budget/Appropriations	14
Copyright/Patent/Trademark	Copyright/Patent/Trademark	11
Animals	Animals	8
Marine/Maritime/Boating/Fisheries	Marine/Maritime/Boating/Fisheries	8
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	8
Environment/Superfund	Environment/Superfund	8
Agriculture	Agriculture	8
Trade (domestic/foreign)	Trade (domestic/foreign)	8
Natural Resources	Natural Resources	8
Waste (hazardous/solid/interstate/nuclear)	Waste (hazardous/solid/interstate/nuclear)	8
Economics/Economic Development	Economics/Economic Development	4
Alcohol and Drug Abuse	Alcohol and Drug Abuse	3
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · fourth_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions in health care reform legislation (including H.R. 3590, the Patient Protection and Affordable Care) pertaining to the medical device excise tax and Medicare reimbursements for medical imaging.

Client expense: — · Firm income: —

Matched citations: H.R. 3590

H.R. 1260111th Congress

Patent Reform Act of 2009

2010 · fourth_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions of the Patent Reform Act (S. 515 and H.R. 1260) relating to apportionment of damages.

Client expense: — · Firm income: —

Matched citations: H.R. 1260

S. 515111th Congress

Patent Reform Act of 2009

2010 · fourth_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions of the Patent Reform Act (S. 515 and H.R. 1260) relating to apportionment of damages.

Client expense: — · Firm income: —

Matched citations: S. 515

S. 510111th Congress

FDA Food Safety Modernization Act

2010 · fourth_quarter · Client: FABIANI & COMPANY ON BEHALF ALNYLAM PHARMACEUTICALS

Open original LDA filing ↗

Cited source text and reported amounts

Patent reform legislation, including S. 510

Client expense: — · Firm income: —

Matched citations: S. 510

Show 21 more cited filings

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · third_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions in health care reform legislation (including H.R. 3590, the Patient Protection and Affordable Care) pertaining to the medical device excise tax and Medicare reimbursements for medical imaging.

Client expense: — · Firm income: —

Matched citations: H.R. 3590

H.R. 1260111th Congress

Patent Reform Act of 2009

2010 · third_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions of the Patent Reform Act (S. 515 and H.R. 1260) relating to apportionment of damages.

Client expense: — · Firm income: —

Matched citations: H.R. 1260

S. 515111th Congress

Patent Reform Act of 2009

2010 · third_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions of the Patent Reform Act (S. 515 and H.R. 1260) relating to apportionment of damages.

Client expense: — · Firm income: —

Matched citations: S. 515

S. 510111th Congress

FDA Food Safety Modernization Act

2010 · third_quarter · Client: FABIANI & COMPANY ON BEHALF ALNYLAM PHARMACEUTICALS

Open original LDA filing ↗

Cited source text and reported amounts

Patent reform legislation, including S. 510

Client expense: — · Firm income: —

Matched citations: S. 510

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · second_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions in health care reform legislation (including H.R. 3590, the Patient Protection and Affordable Care, and H.R.3962, the Affordable Health Care for America Act) pertaining to the medical device excise tax and Medicare reimbursements for medical imaging.

Client expense: — · Firm income: —

Matched citations: H.R. 3590

H.R. 3962110th Congress

Superfund Polluter Pays Act

2010 · second_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions in health care reform legislation (including H.R. 3590, the Patient Protection and Affordable Care, and H.R.3962, the Affordable Health Care for America Act) pertaining to the medical device excise tax and Medicare reimbursements for medical imaging.

Client expense: — · Firm income: —

Matched citations: H.R.3962

H.R. 1260111th Congress

Patent Reform Act of 2009

2010 · second_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions of the Patent Reform Act (S. 515 and H.R. 1260) relating to apportionment of damages.

Client expense: — · Firm income: —

Matched citations: H.R. 1260

S. 515111th Congress

Patent Reform Act of 2009

2010 · second_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions of the Patent Reform Act (S. 515 and H.R. 1260) relating to apportionment of damages.

Client expense: — · Firm income: —

Matched citations: S. 515

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · second_quarter · Client: FABIANI & COMPANY ON BEHALF ALNYLAM PHARMACEUTICALS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3590, the Patient Protection and Affordable Care Act -- therapeutic tax credit provision

Client expense: — · Firm income: —

Matched citations: H.R. 3590

S. 510111th Congress

FDA Food Safety Modernization Act

2010 · second_quarter · Client: FABIANI & COMPANY ON BEHALF ALNYLAM PHARMACEUTICALS

Open original LDA filing ↗

Cited source text and reported amounts

Patent reform legislation, including S. 510

Client expense: — · Firm income: —

Matched citations: S. 510

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · first_quarter · Client: FABIANI & COMPANY ON BEHALF ALNYLAM PHARMACEUTICALS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3590, the Patient Protection and Affordable Care Act -- therapeutic tax credit provision

Client expense: — · Firm income: —

Matched citations: H.R. 3590

S. 510111th Congress

FDA Food Safety Modernization Act

2010 · first_quarter · Client: FABIANI & COMPANY ON BEHALF ALNYLAM PHARMACEUTICALS

Open original LDA filing ↗

Cited source text and reported amounts

Patent reform legislation, including S. 510

Client expense: — · Firm income: —

Matched citations: S. 510

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · first_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions in health care reform legislation (including H.R. 3590, the Patient Protection and Affordable Care, and H.R.3962, the Affordable Health Care for America Act) pertaining to the medical device excise tax and Medicare reimbursements for medical imaging.

Client expense: — · Firm income: —

Matched citations: H.R. 3590

H.R. 3962110th Congress

Superfund Polluter Pays Act

2010 · first_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions in health care reform legislation (including H.R. 3590, the Patient Protection and Affordable Care, and H.R.3962, the Affordable Health Care for America Act) pertaining to the medical device excise tax and Medicare reimbursements for medical imaging.

Client expense: — · Firm income: —

Matched citations: H.R.3962

H.R. 1260111th Congress

Patent Reform Act of 2009

2010 · first_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions of the Patent Reform Act (S. 515 and H.R. 1260) relating to apportionment of damages.

Client expense: — · Firm income: —

Matched citations: H.R. 1260

S. 515111th Congress

Patent Reform Act of 2009

2010 · first_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions of the Patent Reform Act (S. 515 and H.R. 1260) relating to apportionment of damages.

Client expense: — · Firm income: —

Matched citations: S. 515

S. 515111th Congress

Patent Reform Act of 2009

2010 · first_quarter · Client: FABIANI & COMPANY ON BEHALF ALNYLAM PHARMACEUTICALS

Open original LDA filing ↗

Cited source text and reported amounts

S. 515, the Patent Reform Act

Client expense: — · Firm income: —

Matched citations: S. 515

S. 515111th Congress

Patent Reform Act of 2009

2010 · first_quarter · Client: FABIANI & COMPANY ON BEHALF ALNYLAM PHARMACEUTICALS

Open original LDA filing ↗

Cited source text and reported amounts

S. 515, the Patent Reform Act

Client expense: — · Firm income: —

Matched citations: S. 515

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2009 · fourth_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions in health care reform legislation (including H.R. 3590, the Patient Protection and Affordable Care, and H.R.3962, the Affordable Health Care for America Act) pertaining to the medical device excise tax and Medicare reimbursements for medical imaging.

Client expense: — · Firm income: —

Matched citations: H.R. 3590

H.R. 3962110th Congress

Superfund Polluter Pays Act

2009 · fourth_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions in health care reform legislation (including H.R. 3590, the Patient Protection and Affordable Care, and H.R.3962, the Affordable Health Care for America Act) pertaining to the medical device excise tax and Medicare reimbursements for medical imaging.

Client expense: — · Firm income: —

Matched citations: H.R.3962

H.R. 1260111th Congress

Patent Reform Act of 2009

2009 · fourth_quarter · Client: FABIANI & COMPANY ON BEHALF OF MEDRAD INC.

Open original LDA filing ↗

Cited source text and reported amounts

Provisions of the Patent Reform Act (S. 515 and H.R. 1260) relating to apportionment of damages.

Client expense: — · Firm income: —

Matched citations: H.R. 1260

Source: Senate LDA

MARTIN GREEN — Lobbying Disclosure | Poliscope